Cargando…

Mechanisms of QT prolongation by buprenorphine cannot be explained by direct hERG channel block

Buprenorphine is a μ-opioid receptor (MOR) partial agonist used to manage pain and addiction. QT(C) prolongation that crosses the 10 msec threshold of regulatory concern was observed at a supratherapeutic dose in two thorough QT studies for the transdermal buprenorphine product BUTRANS(®). Because Q...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tran, Phu N., Sheng, Jiansong, Randolph, Aaron L., Baron, Claudia Alvarez, Thiebaud, Nicolas, Ren, Ming, Wu, Min, Johannesen, Lars, Volpe, Donna A., Patel, Dakshesh, Blinova, Ksenia, Strauss, David G., Wu, Wendy W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7647070/ https://www.ncbi.nlm.nih.gov/pubmed/33157550 http://dx.doi.org/10.1371/journal.pone.0241362

Ejemplares similares

hERG channel function: beyond long QT
por: Babcock, Joseph J, et al.
Publicado: (2013)

hERG1a N-terminal eag domain–containing polypeptides regulate homomeric hERG1b and heteromeric hERG1a/hERG1b channels: A possible mechanism for long QT syndrome
por: Trudeau, Matthew C., et al.
Publicado: (2011)

Association of the hERG mutation with long-QT syndrome type 2, syncope and epilepsy
por: LI, GUOLIANG, et al.
Publicado: (2016)

hERG-deficient human embryonic stem cell-derived cardiomyocytes for modelling QT prolongation
por: Chang, Yun, et al.
Publicado: (2021)

Clinical Trial in a Dish: Personalized Stem Cell–Derived Cardiomyocyte Assay Compared With Clinical Trial Results for Two QT‐Prolonging Drugs
por: Blinova, Ksenia, et al.
Publicado: (2019)

Functional and pharmacological characterization of an S5 domain hERG mutation associated with short QT syndrome
por: Butler, Andrew, et al.
Publicado: (2019)

Pharmacological activation of the hERG K(+) channel for the management of the long QT syndrome: A review
por: El Harchi, Aziza, et al.
Publicado: (2022)

The electric heart of hERG
por: Islas, León D.
Publicado: (2013)

An Update on the Structure of hERG
por: Butler, Andrew, et al.
Publicado: (2020)

Action potential clamp characterization of the S631A hERG mutation associated with short QT syndrome
por: Butler, Andrew, et al.
Publicado: (2018)

Interleukin-6 inhibition of hERG underlies risk for acquired long QT in cardiac and systemic inflammation
por: Aromolaran, Ademuyiwa S., et al.
Publicado: (2018)

The N-linker region of hERG1a upregulates hERG1b potassium channels
por: Johnson, Ashley A., et al.
Publicado: (2022)

Computational Analysis of the Mode of Action of Disopyramide and Quinidine on hERG-Linked Short QT Syndrome in Human Ventricles
por: Whittaker, Dominic G., et al.
Publicado: (2017)

In silico Assessment of Pharmacotherapy for Human Atrial Patho-Electrophysiology Associated With hERG-Linked Short QT Syndrome
por: Whittaker, Dominic G., et al.
Publicado: (2019)

Electrophysiological characterization of the modified hERG(T) potassium channel used to obtain the first cryo‐EM hERG structure
por: Zhang, Yihong, et al.
Publicado: (2020)

An Insight into the Potassium Currents of hERG and Their Simulation
por: Guidelli, Rolando
Publicado: (2023)

Increased Vulnerability of Human Ventricle to Re-entrant Excitation in hERG-linked Variant 1 Short QT Syndrome
por: Adeniran, Ismail, et al.
Publicado: (2011)

Isoform-Specific Dominant-Negative Effects Associated with hERG1 G628S Mutation in Long QT Syndrome
por: Stump, Matthew R., et al.
Publicado: (2012)

Action Potential Clamp and Pharmacology of the Variant 1 Short QT Syndrome T618I hERG K(+) Channel
por: El Harchi, Aziza, et al.
Publicado: (2012)

Stereoselective Blockage of Quinidine and Quinine in the hERG Channel and the Effect of Their Rescue Potency on Drug-Induced hERG Trafficking Defect
por: Yan, Meng, et al.
Publicado: (2016)

Off-label use of chloroquine, hydroxychloroquine, azithromycin and lopinavir/ritonavir in COVID-19 risks prolonging the QT interval by targeting the hERG channel
por: Zequn, Zheng, et al.
Publicado: (2021)

The Interaction between hERG1 and β1 Integrins Modulates hERG1 Current in Different Pathological Cell Models
por: Chioccioli Altadonna, Ginevra, et al.
Publicado: (2022)

Predicting QT prolongation in humans during early drug development using hERG inhibition and an anaesthetized guinea-pig model
por: Yao, X, et al.
Publicado: (2008)

Rehabilitating drug-induced long-QT promoters: In-silico design of hERG-neutral cisapride analogues with retained pharmacological activity
por: Durdagi, Serdar, et al.
Publicado: (2014)

Structure of the Cyclic Nucleotide-Binding Homology Domain of the hERG Channel and Its Insight into Type 2 Long QT Syndrome
por: Li, Yan, et al.
Publicado: (2016)

Trigger vs. Substrate: Multi-Dimensional Modulation of QT-Prolongation Associated Arrhythmic Dynamics by a hERG Channel Activator
por: Colman, Michael A., et al.
Publicado: (2017)

Identification through action potential clamp of proarrhythmic consequences of the short QT syndrome T618I hERG ‘hotspot’ mutation
por: Du, Chunyun, et al.
Publicado: (2022)

Transfer RNA-mediated restoration of potassium current and electrical correction in premature termination long-QT syndrome hERG mutants
por: Blomquist, Viggo G., et al.
Publicado: (2023)

A systematic strategy for estimating hERG block potency and its implications in a new cardiac safety paradigm
por: Ridder, Bradley J., et al.
Publicado: (2020)

Na(+) Permeation and Block of hERG Potassium Channels
por: Gang, Hongying, et al.
Publicado: (2006)

Stereoselective Inhibition of the hERG1 Potassium Channel
por: Grilo, Liliana Sintra, et al.
Publicado: (2010)

Voltage-Dependent Gating of hERG Potassium Channels
por: Cheng, Yen May, et al.
Publicado: (2012)

Long-Chain Acylcarnitines Regulate the hERG Channel
por: Ferro, Fabio, et al.
Publicado: (2012)

Towards a complete structure of the hERG channel
por: Schmidtke, Peter, et al.
Publicado: (2013)

Ion Conduction through the hERG Potassium Channel
por: Ceccarini, Luisa, et al.
Publicado: (2012)

Kv4.3 Modulates the Distribution of hERG
por: Zhao, Xiao-Jing, et al.
Publicado: (2017)

Lipid regulation of hERG1 channel function
por: Miranda, Williams E., et al.
Publicado: (2021)

Trafficking-Deficient G572R-hERG and E637K-hERG Activate Stress and Clearance Pathways in Endoplasmic Reticulum
por: Wang, Ying, et al.
Publicado: (2012)

Support Vector Machine model for hERG inhibitory activities based on the integrated hERG database using descriptor selection by NSGA-II
por: Ogura, Keiji, et al.
Publicado: (2019)

Mitragynine, an euphoric compound inhibits hERG1a/1b channel current and upregulates the complexation of hERG1a-Hsp90 in HEK293-hERG1a/1b cells
por: Tay, Yea Lu, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_lmerl3hro52qb9s66gal897uvn